Pay in 4 interest-free payments of $5.51 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
A small clinical follow-up study associated EPC therapy with long-term neurological and quality-of-life improvement [40]
This maintenance period was followed by a 5-week follow up period
Assessment of consistency across finngen, PGC, UKB, and other GWAS datasets with meta-analysis To evaluate the consistency of our findings across multiple independent datasets, we conducted Mendelian randomization (MR) analyses using summary genetic data from the FinnGen consortium (R9) ( Psychiatric Genomics Consortium (PGC, and UK Biobank ( The number of individuals included in these analyses ranged from 133,164 to 306,119, as detailed in Supplementary Table S2
Mitochondrial toxins in models of neurodegenerative diseases
US$ 20.07
US$ 27.84
US$ 28.25
US$ 25.65
US$ 26.26
US$ 29.03
US$ 21.73
US$ 21.96
US$ 29.18
US$ 20.26
US$ 20.15
US$ 24.20
US$ 20.67
